Abstract
For ethical and regulatory reasons, in vitro tests for scoring potential toxicities of cosmetics are essential. A test strategy for investigating potential skin sensitization using two human keratinocytic and two human dendritic cell lines has been developed (Mehling et al. Arch Toxicol 86:1273–1295, 2012). Since prohaptens may be metabolically activated in the skin, information on xenobiotic metabolizing enzyme (XME) activities in these cell lines is of high interest. In this study, XME activity assays, monitoring metabolite or cofactor, showed the following: all three passages of keratinocytic (KeratinoSens® and LuSens) and dendritic (U937 und THP-1) cells displayed N-acetyltransferase 1 (NAT1) activities (about 6–60 nmol/min/mg S9-protein for acetylation of para-aminobenzoic acid). This is relevant since reactive species of many cosmetics are metabolically controlled by cutaneous NAT1. Esterase activities of about 1–4 nmol fluorescein diacetate/min/mg S9-protein were observed in all passages of investigated keratinocytic and about 1 nmol fluorescein diacetate/min/mg S9-protein in dendritic cell lines. This is also of practical relevance since many esters and amides are detoxified and others activated by cutaneous esterases. In both keratinocytic cell lines, activities of aldehyde dehydrogenase (ALDH) were observed (5–17 nmol product/min/mg cytosolic protein). ALDH is relevant for the detoxication of reactive aldehydes. Activities of several other XME were below detection, namely the investigated cytochrome P450-dependent alkylresorufin O-dealkylases 7-ethylresorufin O-deethylase, 7-benzylresorufin O-debenzylase and 7-pentylresorufin O-depentylase (while NADPH cytochrome c reductase activities were much above the limit of quantification), the flavin-containing monooxygenase, the alcohol dehydrogenase as well as the UDP glucuronosyl transferase activities.
Similar content being viewed by others
References
Ade N, Martinozzi-Teissier S, Pallardy M, Rousset F (2006) Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J Immunotoxicol 3:189–197
Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Andersen KE, Angers-Loustau A, Aptula A, Bal-Price A, Benfenati E, Bernauer U, Bessems J, Bois FY, Boobis A, Brandon E, Bremer S, Broschard T, Casati S, Coecke S, Corvi R, Cronin M, Daston G, Dekant W, Felter S, Grignard E, Gundert-Remy U, Heinonen T, Kimber I, Kleinjans J, Komulainen H, Kreiling R, Kreysa J, Leite SB, Loizou G, Maxwell G, Mazzatorta P, Munn S, Pfuhler S, Phrakonkham P, Piersma A, Poth A, Prieto P, Repetto G, Rogiers V, Schoeters G, Schwarz M, Serafimova R, Tähti H, Testai E, van Delft J, van Loveren H, Vinken M, Worth A, Zaldivar JM (2011) Alternative (nonanimal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 85:367–485
Arand M, Oesch F (2004) Fremdstoffmetabolismus. In: Marquardt H, Schäfer S (eds) Lehrbuch der Toxikologie. Wissenschaftliche Verlagsanstalt, Stuttgart, pp 89–116
Barker CL, Clothier RH (1997) Human keratinocyte cultures as models of cutaneous esterase activity. Toxicol In Vitro 11:637–640
Baron JM, Höller D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert FK (2001) Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541–548
Basketter D, Crozier J, Hubesch B, Manou I, Mehling A, Scheel J (2012) Optimized testing strategies for skin sensitization—the LLNA and beyond. Regul Toxicol Pharmacol 64:9–16. doi:10.1016/j.yrtph.2012.06.003
Bätz FM, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, von Fritschen U, Weindl G, Schäfer-Korting M (2013) Esterase activity in excised and reconstructed human skin—biotransformation of prednicarbate and the model dye fluorescein diacetate. Eur J Pharm Biopharm 84:374–385. doi:10.1016/j.ejpb.2012.11.008 (Epub 2012 Nov 29)
Bauch C, Kolle SN, Fabian E, Pachel C, Ramirez T, Wiench B, Wruck CJ, van Ravenzwaay B, Landsiedel R (2011) Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals. Toxicol In Vitro 25:1162–1168
Bauch C, Kolle SN, Ramirez T, Eltze T, Fabian E, Mehling A, Teubner W, van Ravenzwaay B, Landsiedel R (2012) Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul Toxicol Pharmacol 63:489–504
Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–771
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Burchell B, Bentley P, Oesch F (1976) Latency of epoxide hydratase and its relationship to that of UDP-glucuronyltransferase. Biochim Biophys Acta 444:531–538
Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT (1994) Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923–936
Butcher NJ, Ilett KF, Minchin RF (2000) Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 57:468–473
Galvão dos Santos G, Reinders J, Ouwehand K, Rustemeyer T, Scheper RJ, Gibbs S (2009) Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol Appl Pharmacol 236:372–382
Garrigue JL, Ballantyne M, Kumaravel T, Lloyd M, Nohynek GJ, Kirkland D, Toutain H (2006) In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N′-diacetyl metabolites. Mutat Res 608:58–71
Glatt H, Gemperlein I, Turchi G, Heinritz H, Doehmer J, Oesch F (1987) Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies. Mol Toxicol 1:313–334
Glatt H, Gemperlein I, Setiabudi F, Platt KL, Oesch F (1990) Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis 5:241–249
Gottwald W (2000) Statistik für Anwender. Wiley-VCH-Verlag, Weinheim
Götz C, Ruwiedel K, Pfeiffer R, Hübenthal U, Edwards R, Carmichael P, Aeby P, Goebel C, Pease C, Fritsche E (2010) The COLIPA skin metabolism project: do in vitro alternatives comprise adequate detoxification capacities for chemical testing in skin? Poster presented at IUTOX 2010
Götz C, Pfeiffer R, Tigges J, Blatz V, Jäckh C, Freytag EM, Fabian E, Landsiedel R, Merk HF, Krutmann J, Edwards RJ, Pease C, Goebel C, Hewitt N, Fritsche E (2012a) Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol 21:358–363. doi:10.1111/j.1600-0625.2012.01486.x
Götz C, Pfeiffer R, Tigges J, Ruwiedel K, Hübenthal U, Merk HF, Krutmann J, Edwards RJ, Abel J, Pease C, Goebel C, Hewitt N, Fritsche E (2012b) Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes. Exp Dermatol 21:364–369. doi:10.1111/j.1600-0625.2012.01478.x
Hagemeyer CE, Bürck C, Schwab R, Knoth R, Meyer RP (2010) 7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver. Anal Biochem 398:104–111
Harris IR, Siefken W, Beck-Oldach K, Brandt M, Wittern KP, Pollet D (2002) Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 1a1 in cultured keratinocytes and reconstructed epidermal models. Skin Pharmacol Appl Skin Physiol 15:59–67. doi:10.1159/000066676
Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14:1633–1638
Hein DW, Bendaly J, Neale JR, Doll MA (2008) Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat. Drug Metab Dispos 36:2452–2459
Henkler F, Luch A, Schäfer-Korting M, Weindl G, Merk H, Landsiedel R, Reisinger K (2011) Abschlussbericht zum Verbund-Forschungsvorhaben Ersatzmethoden zum Tierversuch—Charakterisierung der metabolischen Kapazität von in-vitro-Hautmodellen zum Zwecke der Identifizierung eines optimalen Modells für die Hauttoxizitätsprüfung sowie zu Expositionsabschätzung von Substanzen mit dermaler Biotransformation. Technische Informationsbibliothek und UniversitätsbibliothekTIB Berlin, Reportnr. 0315226A, 0315226B, 0315226C, 0315226D, 0315226E, 01064212; free access under https://getinfo.de/app/download?id=TIBKAT%3a733818099&cluster=tib&term=0315226A&tib=zbwkat&tib=blcp&tib=dkf&tib=rdat&tib=tibkat&tib=blse&tib=sudoc&tib=tema&tib=iud&tib=zbmkm&tib=zbmql&tib=kmoav&tib=arxv&tib=zmat&tib=frpu&tib=etde&tib=temaext&tib=insp&tib=prob&tib=epo&page=1(4 April 2013)
Hirel B, Chesne C, Pailheret JP, Guillouzo A (1995) In Vitro expression of drug metabolizing enzyme activities in human adult keratinocytes under various culture conditions and their response to inducers. Toxicol In Vitro 9:49–56
Hirel B, Watier E, Chesne C, Patoux-Pibouin M, Guillouzo A (1996) Culture and drug biotransformation capacity of adult human keratinocytes from post-mortem skin. Br J Dermatol 134:831–836
Hu T, Khambatta ZS, Hayden PJ, Bolmarcich J, Binder RL, Robinson MK, Carr GJ, Tiesman JP, Jarrold BB, Osborne R, Reichling TD, Nemeth ST, Aardema MJ (2010) Xenobiotic metabolism gene expression in the EpiDerm in vitro 3D human epidermis model compared to human skin. Toxicol In Vitro 24:1450–1463
Husain A, Zhang X, Doll MA, States JC, Barker DF, Hein DW (2007) Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35:721–727
Jäckh C, Blatz V, Fabian E, Guth K, van Ravenzwaay B, Reisinger K, Landsiedel R (2011) Characterization of enzyme activities of cytochrome P450 enzymes, flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and full-thickness skin models. Toxicol In Vitro 25:1209–1214
Jäckh C, Fabian E, van Ravenzwaay B, Landsiedel R (2012) Relevance of xenobiotic enzymes in human skin in vitro models to activate pro-sensitizers. J Immunotoxicol 9:426–438
Janmohamed A, Dolphin CT, Phillips IR, Shephard EA (2001) Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 62:777–786
Jones CR, Lubet RA (1992) Induction of a pleiotropic response by phenobarbital and related compounds. Response in various inbred strains of rats, response in various species and the induction of aldehyde dehydrogenase in Copenhagen rats. Biochem Pharmacol 44:1651–1660
Kawaji A, Ohara K, Takabatake E (1993) An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation. Anal Biochem 214:409–412
Kawakubo Y, Merk HF, Masaoudi TA, Sieben S, Blomeke B (2000) N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J Pharmacol Exp Ther 292:150–155
Kawashima Y, Someya Y, Sato S, Shirato K, Jinde M, Ishida S, Akimoto S, Kobayashi K, Sakakibara Y, Suzuki Y, Tachiyashiki K, Imaizumi K (2011) Dietary zinc-deficiency and its recovery responses in rat liver cytosolic alcohol dehydrogenase activities. J Toxicol Sci 36:101–108
Kimber I, Dearman RJ, Basketter DA (2013) Dendritic cells and the assessment in vitro of skin sensitizing potential. Cutan Ocul Toxicol 32:54–59
Lichter J, Heckelen A, Fischer K, Blomeke B (2008) Expression of N-acetyltransferase in monocyte-derived dendritic cells. J Toxicol Environ Health A 71:960–964
Liu L, Von Vett A, Zhang N, Walters KJ, Wagner CR, Hanna PE (2007) Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Chem Res Toxicol 20:1300–1308
Magnusson B, Kligman AM (1969) The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 52:268–276
Masters BSS, Williams CH Jr, Kamin H (1967) The preparation and properties of microsomal TPNH-cytochrome c reductase from pig liver. Methods Enzymol 10:565–573
McCall BP, Horwitz IB, Feldman SR, Balkrishnan R (2005) Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers’ compensation analysis of Oregon, 1990–1997. Arch Dermatol 141:713–718
McCracken NW, Blain PG, Williams FM (1993) Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem Pharmacol 45:31–36
Mehling A, Eriksson T, Eltze T, Kolle S, Ramirez T, Teubner W, van Ravenzwaay B, Landsiedel R (2012) Non-animal test methods for predicting skin sensitization potentials. Arch Toxicol 86:1273–1295
Natsch A (2010) The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers—functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol Sci 113:284–292
Neis MM, Wendel A, Wiederholt T, Marquardt Y, Joussen S, Baron JM, Merk HF (2010) Expression and induction of cytochrome P450 isoenzymes in human skin equivalents. Skin Pharmacol Physiol 23:29–39
Nims RW, Prough RA, Jones CR, Stockus DL, Dragnev KH, Thomas PE, Lubet RA (1997) In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants Blonazepam and Diazepam. Drug Metab Dispos 25:750–756
Niwa T, Shiraga T, Yamasaki S, Ishibashi K, Ohno Y, Kagayama A (2003) In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 33:717–729
Nohynek GJ, Duche D, Garrigues A, Meunier PA, Toutain H, Leclaire J (2005) Under the skin: biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol Lett 158:196–212
Nukada Y, Ashikaga T, Sakaguchi H, Sono S, Mugita N, Hirota M, Miyazawa M, Ito Y, Sasa H, Nishiyama N (2011) Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT). Contact Dermat 65:343–353
Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R (2007) Drug metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 39:659–698
Oesch-Bartlomowicz B, Oesch F (2007) Mechanisms of toxication and detoxication which challenge drug candidates and drugs. In: Triggle D, Taylor J (eds) Comprehensive medicinal medicine. Elsevier, Philadelphia, PA, pp 193–214
Okamura K, Ishii Y, Ikushiro S, Mackenzie PI, Yamada H (2006) Fatty acyl-CoA as an endogenous activator of UDP-glucuronosyltransferases. Biochem Biophys Res Commun 345:1649–1656
Pham MA, Magdalou J, Siest G, Lenoir MC, Bernard BA, Jamoulle JC, Shroot B (1990) Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis. J Invest Dermatol 94:749–752
Python F, Goebel C, Aeby P (2007) Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol 220:113–124
Qin Z (2012) The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221:2–11
Raleigh SM, Wanogho E, Burke MD, McKeown SR, Patterson LH (1998) Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone di-N-oxide prodrug. Int J Radiat Oncol Biol Phys 42:763–767
Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide induced cutaneous drug reactions. J Invest Dermatol 114:1164–1173
Russell WMS, Burch RL (1959) The Principles of Humane Experimental Technique. Methuen, London. Reprinted by UFAW, 1992: 8 Hamilton Close, South Mimms, Potters Bar, Herts EN6 3QD England. ISBN 0 900767 78 2
Saeki M, Saito Y, Nagano M, Teshima R, Ozawa S, Sawada JI (2002) mRNA expression of multiple cytochrome P450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 127:333–336
Sakaguchi H, Ashikaga T, Miyazawa M et al (2006) Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 20:774–784
Schnuch A, Westphal G, Mössner R, Uter W, Reich K (2011) Genetic factors in contact allergy—review and future goals. Contact Dermat 64:2–23. doi:10.1111/j.1600-0536.2010.01800.x
Shen AL, Kasper CB (1993) Protein and gene structure and regulation of NADPH-CytochromeP450 oxidoreductase. Springer, New York
Stormer E, Roots I, Brockmoller J (2000) Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity. Br J Clin Pharmacol 50:553–561
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL (2002) Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 30:845–852
Teunis M, Corsini E, Smits M, Madsen CB, Eltze T, Ezendam J, Galbiati V, Gremmer E, Krul C, Landin A, Landsiedel R, Pieters R, Rasmussen TF, Reinders J, Roggen E, Spiekstra S, Gibbs S (2012) Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 27:1135–1150. doi:10.1016/j.tiv.2012.06.004
Ubeaud G, Schiller CD, Hurbin F, Jaeckh D, Coassolo P (1999) Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation of Benzydamine. Eur J Pharm Sci 8:255–260
Wulferink M, González J, Goebel C, Gleichmann E (2001) T cells ignore aniline, a prohapten, but respond to its reactive metabolites generated by phagocytes: possible implications for the pathogenesis of toxic oil syndrome. Chem Res Toxicol 14:389–397
Xiong Y, Bernardi D, Bratton S, Ward MD, Battaglia E, Finel M, Drake RR, Radominska-Pandya A (2006) Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis. Biochemistry 45:2322–2332
Yeung CK, Rettie AE (2006) Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activity. Methods Mol Biol 320:157–162
Conflict of interest
Some of the authors were involved in the development of skin sensitization in vitro assays.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabian, E., Vogel, D., Blatz, V. et al. Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro. Arch Toxicol 87, 1683–1696 (2013). https://doi.org/10.1007/s00204-013-1090-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-013-1090-9